Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trichuris Suis Ova in Autism Spectrum Disorders

Trial Profile

Trichuris Suis Ova in Autism Spectrum Disorders

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jun 2018

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2014 Primary endpoint (Aberrant Behavior Checklist - irritability) has not been met, as reported in a Coronado Biosciences media release.
    • 26 Jun 2014 Results will be presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
    • 26 Jun 2014 Status changed from active, no longer recruiting to completed, based on a Coronado Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top